Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • RSP vs MRNA✓SelectedUSD · MRNARSP vs MRNA performance historyLatest closeAs of+0.20%11/13
Stock and ETF performance explorer

RSP vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+19.5%
MRNA return
+755.5%
Excess return
-736.0%
Maximum drawdown
-7.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.2%-3.4%+3.6%+0.2%
7D+2.4%-12.1%+14.5%+2.5%
30D+4.3%-1.3%+5.6%+4.3%
3M-0.3%+250.9%-251.3%-2.7%
6M+9.8%+343.0%-333.2%+4.9%
YTD+16.8%+657.4%-640.6%+6.2%
1Y+19.5%+794.9%-775.4%+5.1%
All+19.5%+755.5%-736.0%+5.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling